Диссертация (1154915), страница 19
Текст из файла (страница 19)
Central aortic blood pressure. 2nd edition. ESH,2015. – Р. 34-40.105. Laurent S. on behalf of the European Network for Noninvasive Investigationof Large Arteries. Expert consensus document on arterial stiffness: methodologicalissues and clinical applications./ Laurent S., Cockcroft J., Van Bortel L. et al.
// EurHeart J. – 2006. - № 27. _Р. 2588-2605.106. Law M.R., Morris J.K., Wald N.J. Use of blood pressure lowering drugs inthe prevention of cardiovascular disease: meta-analysis of 147 randomized trials incontext of expectations from prospective epidemiological studies. BMJ. 2009; 338:1665-1683.107. Lee S.H.. Effects of Atrial Fibrillation on Arterial Stiffness in Patients WithHypertension.
/Lee S.H., Choi S., JungJ.H., Lee N. //Angiology. – 2008. - №59(4).– Р. 459-463.108. Letsas K.P., Efremidis M., Giannopoulos G. et al. CHADS2 and CHA2DS2VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrialfibrillation.Europace 2014; 16:202-207109. Levy R.L. Transient tachycardia: prognostic significance alone and inassociation with transient hypertension. /Levy R.L., White P.D., Stroud W.D.,Hillman C.C.// JAMA. – 1945.
- №129. - Р. 585–588.110. Li D., Melnyk P., Feng J. et al. Effects of experimental heart failure on atrialcellular and ionic electrophysiology. Circulation 2000;101: 2631–2638.111. Lloyd-Jones D.M. Lifetime risk for development of atrial fibrillation: theFramingham Heart Study. /Lloyd-Jones D.M., Wang T.J., Leip E.P. et al.//.Circulation. - 2004. - №110. – Р. 1042–1046.117112. Lönnerholm S., Blomstrom P., Nilsson L.,et al. Effects of the maze operationon health-related quality of life in patients with atrial fibrillation. Circulation,2000;101:2607—2611.113. Mahmud A.
Beta-blockers reduce aortic stiffness in hypertension butnebivolol, not atenolol, reduces wave reflection. /Mahmud A., Feely J. //Am JHypertens. - 2008. - №21(6). - Р. 663-667.114. Mancia G. Guidelines for the Management of Arterial Hypertension: theTask Force for the Management of Arterial Hypertension of the European Societyof Hypertension (ESH) and of the European Society of Cardiology (ESC). /Mancia G., De Backer G., Dominiczak A. et al.// J Hypertens. – 2013.
- №34. – Р.2159–2219.115. Mancia G., Fagard R. et al. ESH/ESC Guidelines for the management ofarterial hypertension. Eur Heart J. – 2013. - №34. – Р. 2159–2219.116. ManciaG.ReappraisalofEuropeanguidelinesonhypertensionmanagement: a European Society of Hypertension Task Force document.
/ManciaG., Laurent S., Agabiti-Rosei E. et al.//J Hypertens. – 2009. - №27. – Р. 2121-2125.117. Manolis J. Hypertension and atrial fibrillation: diagnostic approach,prevention and treatment. Position paper of the Working Group "HypertensionArrhythmias and Thrombosis" of the European Society of Hypertension. /ManolisJ., Rosei EA, Coca A. //J Hypertens. - 2012. - №30. – Р.239–252.118. Marott S.C.W.
Antihypertensive Treatment and Risk of Atrial Fibrillation. ANationwide Study. /Marott S.C.W., Nielsen S.F., BennM., Nordestgaard B.G. //EurHeart J. – 2014. - №35(18). – Р. 1205-1214.119. Mitchell G.F. Pulse pressure and risk of new-onset atrial fibrillation./Mitchell G.F., Vasan R.S., Keyes M.J., Parise H., Wang T.J. at al.// JAMA. - 2007.- №297. – Р. 709–715.120.
Mitu O. Association of health-related quality of life with cardiovascular riskfactors and subclinical atherosclerosis in non-diabetic asymptomatic adults. /MituO., Roca M., Leon M.M. et al. // Biomedical Research. - 2016. - №27 (3). – Р.687-694118121. Miyoshi H. Association of left atrial reservoir function with left atrialstructural remodeling related to left ventricular dysfunction in asymptomaticpatients with hypertension: evaluation by two-dimensional speckle-trackingechocardiography./Miyoshi H., Oishi Y., Mizuguchi Y. et al.// Clin Exp Hypertens.-2014 - №1.
– Р. 11.122. Morcet J. Associations between heart rate and other risk factors in a largeFrench population. / Morcet J., Safar M., Thomas F., Guize L., Benetos A. //JHypertens. – 1999. - №17. - Р. 1671–1676123. Munakata M. Effect of Valsartan ahd Nifedipine Coat-Core on systemicarterial stiffness in hypertensive patients.
/Munakata M., Nagasaki A., NunokawaT. et al. //Am J Hypertens – 2004. - №17(11). - Р. 1050-1055.124. Nattel S. Electrophysiologic remodeling: are ion channels static players ordynamic movers? J Cardiovasc Electrophysiol. – 1999. - №10. – Р. 1553–1556.125. Nelson M., Noninvasive Measurement of Central Vascular Pressures WithArterial Tonometry: Clinical Revival of the Pulse Pressure Waveform? /Nelson M.,Stepanek J., Cevette M. et al. //Mayo Clin Proc. – 2010.
- № 85(5). – Р. 460–472.126. Nelson S.E. Impact of Chronic Kidney Disease on Risk of Incident AtrialFibrillation and Subsequent Survival in Medicare Patients. / Nelson S.E., ShroffG.R., Shuling Li et al.// J Am Heart Assoc. - 2012. - № 1(4). – Р. e002097127. Nikitin N.P. Effect of Age and Sex on Left Atrial Morphology and Function./Nikitin N.P., Witte K.K.A., Thackray S.D.R. et al. //Eur J Echocardiography. –2003. - №4. – Р. 36–42.128.
Nishimura R.A. Failure of calcium channel blockers to improve ventricularrelaxation in humans. /Nishimura R.A., Schwartz R.S., Holmes D.R., Tajik A.J.//JACC. – 1993. - №21. – Р. 182–188.129. O’Neal W.T. Resting Heart Rate and Incident Atrial Fibrillation in theElderly./ O’Neal W.T., Almahmoud M.F., Soliman E.Z. //Pacing and ClinicalElectrophysiology. – 2015.
- №38 (5). – Р. 591–597130. Okin P.M. All-cause and cardiovascular mortality in relation to changingheart rate during treatment of hypertensive patients with electrocardiographic left119ventricular hypertrophy. /Okin P.M., Kjeldsen S.E., Julius S., Hille D.A., DahlofB., Edelman J.M., Devereux R.B. //Eur Heart J. – 2010. - №31. – Р.2271–2279.131. Palatini P. Heart rate as a cardiovascular risk factor: do women differ frommen? Ann Med. – 2001. – № 33. – Р. 213–221.132. Palatini P. Role of Elevated Heart Rate in the Development ofCardiovascular Disease in Hypertension. J Hypertens.
2011. – №58. - Р. 745-750.133. Palatini P. Identification and management of the hypertensive patient withelevated heart rate: statement of a European Society of Hypertension ConsensusMeeting. /Palatini P., Benetos A., Grassi G., Julius S., Kjeldsen S.E., Mancia G. etal. // J Hypertens. 2006. - №24. - Р.603– 610.134. Palatini P. Resting heart rate as a predictor of body weight gain in the earlystage of hypertension./ Palatini P., Mos L., Santonastaso M. et al. //Obesity. – 2011.- № 19. - Р. 618–623.135.
Palatini P. Predictive value of clinic and ambulatory heart rate for mortalityin elderly subjects with systolic hypertension. / Palatini P., Thijs L., Staessen J.A.,Fagard R.H., Bulpitt C.J., Clement D.L. et al. //Arch Intern Med. – 2002. - №162.– Р. 2313–2321.136. Paquette M. Role of gender and personality on quality-of-life impairment inintermittent atrial fibrillation.
/Paquette M., Roy D., Talajic M. et al.// Am JCardiol. – 2000. - №86. – Р. 764—768.137. Paraskevaidis I.A. Left atrial functional reserve in patients with nonischemicdilated cardiomyopathy: an echocardiographic dobutamine study. /ParaskevaidisI.A., Dodouras T., Adamopoulos S. et al.// Chest. 2002. - № 122. - Р.
1340-1347.138. Paraskevaidis I.A. Evaluation of left atrial longitudinal function in patientswith hypertrophic cardiomyopathy: a tissue Doppler imaging and two-dimensionalstrain study. /Paraskevaidis I.A., Panou F., Papadopoulos C. et al. // Heart. - 2009.- № 95. – Р. 483-489.139. Park B.J. Association between resting heart rate and arterial stiffness inKorean adults. /Park B.J., Lee H.R., Shim J.Y., Lee J.H., Jung D.H., Lee Y.J.//Arch Cardiovasc Dis. – 2010. - №103. – Р.
246-252.120140. Paul L. Resting heart rate pattern during follow-up and mortality inhypertensive patients. /Paul L., Hastie C.E., Li W.S., Harrow C., Muir S. et al.// JHypertens. – 2010. - №55. – Р. 567–574.141. Poulter N.R. ASCOT Investigators. Baseline heart rate, antihypertensivetreatment, and prevention of cardiovascular outcomes in ASCOT (AngloScandinavian Cardiac Outcomes Trial). /Poulter N.R., Dobson J.E., Sever P.S.,Dahlof B., Wedel H., Campbell N.R.